Skip to content

Drägerwerk raises annual targets again

The medical and safety technology group Drägerwerk has raised its targets again at the end of the year. The SDax-listed company announced on Wednesday evening in Lübeck that both net sales and the operating profit margin for 2023 are likely to be better than recently forecast.

A company flag flies in front of the Drägerwerk headquarters. Photo.aussiedlerbote.de
A company flag flies in front of the Drägerwerk headquarters. Photo.aussiedlerbote.de

Security technology group - Drägerwerk raises annual targets again

The medical and safety technology group Drägerwerk has raised its targets again at the end of the year. The SDax-listed company announced on Wednesday evening in Lübeck that both net sales and the operating profit margin for 2023 are likely to be better than previously forecast.

In terms of revenue, the management now expects a currency-adjusted increase of more than eleven percent; previously, the upper end of the range was eleven percent. The operating margin is expected to be over four percent instead of between two and four percent as previously.

For 2022, Drägerwerk had reported net sales of around EUR 3.05 billion and an operating loss of EUR 88.6 million. This corresponds to a margin of -2.9 percent.

Announcement

Read also:

Drägerwerk, located in the city of Lübeck in the German state of Schleswig-Holstein, is part of the SDAX index. Recently, the company revised its annual targets, predicting a significant increase in net sales and operating profit margin for 2023. In 2022, Drägerwerk reported net sales of approximately 3.05 billion Euros and an operating loss of 88.6 million Euros, resulting in a margin of -2.9%. Drägerwerk's strong presence in the Medicine sector contributes to its success in Germany and globally.

Source: www.stern.de

Comments

Latest